Frisina N, Lasco A, Buemi M, Costa G
Ann Endocrinol (Paris). 1983;44(4):243-6.
Administration of ACTH beta 1-24 (0.25 mg, i.m.) in six healthy subjects reduces blood prolactin response to sulpiride (100 mg, i.m.). Dexamethasone (2 mg, orally, given at 11.00 p.m. of preceding day) blocks blood prolactin response to insulin-induced hypoglycemia (0.20 U. kg of "Actrapid" Novo, i.v.) in six voluntary healthy subjects. Intravenous naloxone (0.4 mg/Kg of body weight) blocks in man blood prolactin response to insulin-induced hypoglycemia. On the basis of the above data we can hypothesize that ACTH and dexamethasone have influenced by a feed-back mechanism the lypocorticotropic system. Such system by beta-endorphin release can modulate the secretion of prolactin. Thus inhibition of the lipocorticotropic system may be responsible for the reduced response of the prolactin system to stimulation by sulpiride or hypoglycemic stress.
对6名健康受试者肌肉注射促肾上腺皮质激素β1 - 24(0.25毫克)可降低血液中催乳素对舒必利(100毫克,肌肉注射)的反应。地塞米松(2毫克,在前一天晚上11点口服)可阻断6名自愿参与的健康受试者血液中催乳素对胰岛素诱导的低血糖(0.20单位/千克“诺和灵”,静脉注射)的反应。静脉注射纳洛酮(0.4毫克/千克体重)可阻断人体血液中催乳素对胰岛素诱导的低血糖的反应。基于上述数据,我们可以推测促肾上腺皮质激素和地塞米松通过反馈机制影响了促脂素系统。该系统通过释放β - 内啡肽可调节催乳素的分泌。因此,促脂素系统的抑制可能是催乳素系统对舒必利刺激或低血糖应激反应降低的原因。